Cardiac Septal Hypertrophy in the Fetus of Diabetic Mother and Its Effect on Postnatal Cardiac Function
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01599026|
Recruitment Status : Unknown
Verified May 2012 by heba mohamed, Ain Shams Maternity Hospital.
Recruitment status was: Enrolling by invitation
First Posted : May 15, 2012
Last Update Posted : May 15, 2012
|Condition or disease|
|Cardiology in Fetus of Diabetic Mother|
|Study Type :||Observational|
|Estimated Enrollment :||120 participants|
|Official Title:||Cardiac Septal Hypertrophy in the Fetus of Diabetic Mother and Its Effect on Postnatal Cardiac Function|
|Study Start Date :||April 2012|
|Estimated Primary Completion Date :||February 2013|
|Estimated Study Completion Date :||March 2013|
- To study interventricular septum thickness in fetus of diabetic mother and correlate it with good glycemic control. [ Time Frame: one year ]To study interventricular septum thickness in fetus of diabetic mother and correlate it with good glycemic control during third trimester of pregnancy.
- cardiac function in infant of diabetic mother [ Time Frame: one year ]To correlate postnatal cardiac function to interventricular septum thickness to reach cut of value of septum thickness for prenatal prediction of symptomatic cardiomyopathy in infant of diabetic mother.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01599026
|Cairo, Egypt, 44511|